Andrew C. Chan
CIK: 0002131504
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVS
Corvus Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Chan Andrew C.
Chan Andrew C. (SEC CIK 0002131504) files insider reports with the SEC as Director of Corvus Pharmaceuticals, Inc. (CRVS).
Signal8 holds 2 ownership filings by Chan Andrew C. (1 Form 3, 1 Form 4), filed on Apr 27, 2026. Those filings report 1 transaction, the latest on Apr 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chan Andrew C.'s filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Chan Andrew C.
- Apr 23, 2026: Grant or award of CRVS derivative securities (Form 4, code A).
Other insiders filing for Corvus Pharmaceuticals, Inc. (CRVS)
- Moore David Scott, Director
- CLARK IAN T, Director
- Grais Linda, Director
- Thompson Peter A., Director
- van den Broek Richard, Director
- MILLER RICHARD A MD, President and CEO